AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Stagge, V Seufferlein, T Durschmied, D Menke, A Adler, G Beil, M
Citation: V. Stagge et al., Integrin-mediated differentiation of a pancreatic carcinoma cell line is independent of FAK or MAPK activation levels, PANCREAS, 23(3), 2001, pp. 236-245

Authors: Poch, B Gansauge, F Schwarz, A Seufferlein, T Schnelldorfer, T Ramadani, M Beger, HG Gansauge, S
Citation: B. Poch et al., Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: Evidence for a cyclin D1-dependent cell cycle progression, PANCREAS, 23(3), 2001, pp. 280-287

Authors: Sturany, S Van Lint, J Muller, F Wilda, R Hameister, H Hocker, M Brey, A Gern, U Vandenheede, J Gress, T Adler, G Seufferlein, T
Citation: S. Sturany et al., Molecular cloning and characterization of the human protein kinase D2 - A novel member of the protein kinase D family of serine threonine kinases, J BIOL CHEM, 276(5), 2001, pp. 3310-3318

Authors: Ellenrieder, V Hendler, SF Boeck, W Seufferlein, T Menke, A Ruhland, C Adler, G Gress, TM
Citation: V. Ellenrieder et al., Transforming growth factor beta 1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation, CANCER RES, 61(10), 2001, pp. 4222-4228

Authors: von Wichert, G Jehle, PM Hoeflich, A Koschnick, S Dralle, H Wolf, E Wiedenmann, B Boehm, BO Adler, G Seufferlein, T
Citation: G. Von Wichert et al., Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells, CANCER RES, 60(16), 2000, pp. 4573-4581

Authors: Seufferlein, T Van Lint, J Liptay, S Adler, G Schmid, RM
Citation: T. Seufferlein et al., Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations, GASTROENTY, 116(6), 1999, pp. 1441-1452

Authors: Grewe, M Gansauge, F Schmid, RM Adler, G Seufferlein, T
Citation: M. Grewe et al., Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70(s6K) pathway in human pancreatic cancer cells, CANCER RES, 59(15), 1999, pp. 3581-3587
Risultati: 1-7 |